Browsing Tag
Orthopaedics
2 posts
Smith+Nephew Q3 2025: Can the CATALYSTEM rollout and REGENETEN momentum offset VBP risks?
Smith+Nephew raises 2025 free cash flow guidance to USD 750 million as margin growth accelerates. Find out what’s driving the company’s transformation.
Smith+Nephew expands margins and cash flow—What it means for shareholders
Smith+Nephew, a global leader in medical technology, has reported a strong financial performance for 2024, highlighting steady revenue…